Welsh, Carson, Anderson & Stowe (“WCAS”), a leading private equity firm focused exclusively on the healthcare and technology industries, announced today that it is committing up to $250 million to a strategic partnership with Kiniciti, a newly-formed platform. Kiniciti will invest in non-therapeutic companies supporting cell and gene therapy (“CGT”) innovation which have the potential to transform the cell and gene therapy ecosystem and deliver the promise of CGT to impact patients’ lives.
Read the full article: WCAS Commits $250M in a Strategic Partnership with Kiniciti, a Newly-Formed Platform Investing in Cell and Gene Therapy Companies //
Source: https://www.prnewswire.com/news-releases/welsh-carson-anderson–stowe-commits-250-million-in-a-strategic-partnership-with-kiniciti-a-newly-formed-platform-investing-in-cell-and-gene-therapy-companies-301218733.html